STAT June 28, 2024
Nicholas Florko

WASHINGTON — Vape manufacturers are taking a victory lap over a Supreme Court decision that could dramatically weaken the Food and Drug Administration’s power to regulate tobacco and nicotine products as regulators see fit.

The court on Friday overturned a judicial rule, known as the Chevron doctrine, which instructed courts to defer to regulators on certain legal issues. Vape manufacturers see the decision as a powerful weapon in their fight against the FDA’s efforts to ban the majority of vapes lining store shelves.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
Related Articles:
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
STAT+: FDA approves Eli Lilly’s early Alzheimer’s treatment
Supreme Court to weigh whether the FDA was heavy-handed with flavored e-cigarette products
STAT+: How controversial was the decision by FDA’s Peter Marks to approve Sarepta’s gene therapy? Check its footnotes
FDA Finds Infectious H5N1 Bird Flu Virus In 14% Of Raw Milk Samples

Share This Article